SPAC Research & Analysis

SPAC research, analysis, and data trusted by leading SPAC sponsors, investors, banks, and more.

SPAC Research & Analysis

Boardroom Alpha writes daily SPAC analysis covering the SPAC market, SPAC deals and mergers, IPOs, sponsors and more. 

Daily SPAC Update – March 20, 2026

Another Quantum DeSPAC as DMY becomes Horizon Quantum. Inflection Point III Increases PIPE. UY Scuti Moves Vote Again. Blue Water IV IPOs for $125 Million.

Daily SPAC Update – March 19, 2026

SPAC IPOs Slow as BHAV Acquisition’s IPO Makes it Only 6 for March. Integrated Wellness Extension and Voyager + Veraxa Biotech Deal Approved. Quartzsea Deal Terminated.

Daily SPAC Update – March 18, 2026

DMY Squared’s Quantum Deal Approved. Winvest Acquisition Extension Approved. Pelican Deal Vote Delayed. Alphatime Sets Extension Vote. Cayson Goes to Vote.

Daily SPAC Update – March 17, 2026

Harry You’s DMY Squared Deal Vote with Horizon Quantum Today. Pelican Acquisition Deal Vote. Abra and GNQ Insilico Deals Announced. Merlin DeSPAC.

Daily SPAC Update – March 13, 2026

Pono Capital Four Downsized $120M IPO. Inflection Point IV + Merlin Deal Approved. Haymaker 4 + Concrete Partners Deal Vote Today.

Daily SPAC Update – March 12, 2026

Metals Acquisition II IPOs. Inflection Point IV + Merlin and Voyager + VERAXA Deal Votes. Harry You Talks Up Quantum Deal for DMY.

Daily SPAC Update – March 10, 2026

Plum IV + Controlled Thermal Resources and Calisa + GoodVision AI Deals. TLGY + Stabecoin X Assets Deal Vote. DMY Squared PIPE Updates.

Daily SPAC Update – March 9, 2026

Drugs Made in America CEO Lynn Stockwell Terminated after Improper Withdrawals. DMY Squared Increases PIPE. Plum IV $4.7B Deal with CTR.

Daily SPAC Update – March 5, 2026

Gundlach’s Bleichroeder II Does Quantum Deal with Pasqal. AParadise Target Enhanced Issues Investor Deck. Goldenstone Sets Extension Vote.

Know Who Drives Return

Revolutionary quantitative assessments of officers and directors